-
2025-522440-41-00
4
2026-04-27
Hidradenitis Suppurativa
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-521456-35-00
4
2026-04-13
Mild to moderate asthma
-
2025-523657-34-00
5
2026-04-13
Obesity
-
2025-523263-37-00
10
2026-04-08
Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal
-
2025-522578-35-00
4
2026-03-30
Atopic Dermatitis
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2024-518210-81-00
5
2026-03-18
Advanced Hepatocellular Carcinoma
-
2025-522642-44-00
4
2026-03-18
CHRONIC SPONTANEOUS URTICARIA
-
2025-521416-19-00
4
2026-03-12
Recurrence of Clostridioides difficile Infection
-
2025-521762-99-00
5
2026-03-09
acute ischemic stroke
-
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
-
2025-521642-14-00
4
2026-03-05
Multiple System Atrophy
-
2025-521670-34-00
5
2026-03-04
Acute coronary syndrome (ST-elevation myocardial infarction [STEMI] or
-
2024-519903-88-00
4
2026-03-03
Prediabetes
-
2025-521035-37-00
5
2026-03-02
Immune system diseases
-
2024-516411-24-00
5
2026-02-25
Insomnia Disorder
-
2024-516356-18-00
5
2026-02-17
Atherosclerotic cardiovascular disease (ASCVD)
-
2025-521849-25-00
4
2026-02-17
Chronic Graft-Versus-Host Disease
-
2025-522640-41-00
4
2026-02-13
Asthma
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)